NBTY Global Health Sciences $40 Mil. Acquisition Approval Pending
This article was originally published in The Tan Sheet
Executive Summary
NBTY intends to keep intact bankrupt Global Health Sciences' contract manufacturing business instead of using the acquired capacity for its own purposes, the supplement manufacturer told analysts during a conference call April 26.
You may also be interested in...
NBTY Direct Response Business Unaffected By Mail Concerns
NBTY's Puritan's Pride mail order and e-commerce business fared well despite recent consumer anxiety about the mail, CFO Harvey Kamil told analysts during a fiscal year-end conference call Nov. 7
Herbalife Management Conflicts Of Interest Questioned By Investment Groups
Herbalife execs' dual responsibilities as directors of the firm and trustees in the estate of its founder could produce "serious conflicts of interest," two investment groups charge in a July 24 letter to the board.
NBTY
Global Health Sciences acquisition provides much needed manufacturing capability and $100 mil. in yearly revenue, company says after transaction's close May 25. NBTY's sports nutrition, meal replacement and diet products expected to get a boost from $40 mil. deal; GHS' sports nutrition and weight control lines fall under its Omni-Pak business, while its D&F subsidiary produces herbals, vitamins and minerals. GHS adds 400,000 sq. ft. in facilities to NBTY's continuing operations. NBTY says it plans to keep GHS' operations intact rather than integrating (1"The Tan Sheet" April 30, p. 13)